Mirum Pharmaceuticals, Inc. MIRM Product sales, net — Product sales, net

Other product segments

Similar metrics at other companies

NBIXNet product sales — Total revenues

$811M+43.9%

BMYNet product sales — Total Revenues

$11.17B+2.6%

VRTXProduct revenues, net — Product revenues, net

$2.99B+8.2%

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

BIIBProduct revenue, net — Total Revenue

$1.75B+1.5%

JAZZProduct sales, net — Revenue from Contract with Customer, Excluding Assessed Tax

$1.03B+22.1%

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s product sales, net — product sales, net?

Mirum Pharmaceuticals, Inc. (MIRM) reported product sales, net — product sales, net of $159.88M in Q1 2026.

How has Mirum Pharmaceuticals, Inc.'s product sales, net — product sales, net changed year-over-year?

Mirum Pharmaceuticals, Inc.'s product sales, net — product sales, net increased by 43.3% year-over-year, from $111.59M to $159.88M.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s product sales, net — product sales, net?

Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s product sales, net — product sales, net has grown at a 259.0% compound annual growth rate (CAGR), from $3.14M to $521.31M.

What does product sales, net — product sales, net mean?

This metric represents the total revenue generated from the sale of pharmaceutical products after accounting for variable considerations such as rebates, discounts, returns, and allowances. It serves as a primary indicator of commercial adoption and market penetration for the company's therapeutic portfolio. Tracking this figure allows investors to assess the underlying demand for the company's approved treatments and the effectiveness of its commercialization strategy.